UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000055758
Receipt number R000063726
Scientific Title Impact of antibiotic use in patients after hematopoietic stem cell transplantation on graft-versus-host disease outcomes: a systematic review and meta-analysis
Date of disclosure of the study information 2024/10/15
Last modified on 2025/04/07 12:13:09

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Impact of antibiotic use in patients after hematopoietic stem cell transplantation on graft-versus-host disease outcomes: a systematic review and meta-analysis

Acronym

Impact of antibiotic use in patients after hematopoietic stem cell transplantation on graft-versus-host disease outcomes

Scientific Title

Impact of antibiotic use in patients after hematopoietic stem cell transplantation on graft-versus-host disease outcomes: a systematic review and meta-analysis

Scientific Title:Acronym

Impact of antibiotic use in patients after hematopoietic stem cell transplantation on graft-versus-host disease outcomes

Region

Japan


Condition

Condition

graft-versus-host disease

Classification by specialty

Infectious disease

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate an impact of antibiotic use in patients after hematopoietic stem cell transplantation on graft-versus-host disease outcomes

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

graft-versus-host disease-related mortality

Key secondary outcomes



Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

observational and interventional studies addressing graft-versus-host disease outcomes of antibiotic use in patients after hematopoietic stem cell transplantation

Key exclusion criteria

studies without description of outcome of interest; review articles; conference reports

Target sample size



Research contact person

Name of lead principal investigator

1st name Hiroshi
Middle name
Last name ItIto

Organization

Tokyo Medical University Ibaraki Medical Center

Division name

Division of General Internal Medicine

Zip code

300-0332

Address

3-20-1, Chuo, Ami-machi, Inashiki-gun, Ibaraki, Japan

TEL

0298871161

Email

itohirokan@yahoo.co.jp


Public contact

Name of contact person

1st name Hiroshi
Middle name
Last name Ito

Organization

Tokyo Medical University Ibaraki Medical Center

Division name

Division of General Internal Medicine

Zip code

300-0332

Address

3-20-1, Chuo, Ami-machi, Inashiki-gun, Ibaraki, Japan

TEL

0298871161

Homepage URL


Email

itohirokan@yahoo.co.jp


Sponsor or person

Institute

Tokyo Medical University

Institute

Department

Personal name



Funding Source

Organization

Tokyo Medical University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

-

Address

-

Tel

0298871161

Email

itohirokan@yahoo.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 10 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2024 Year 10 Month 07 Day

Date of IRB

2024 Year 10 Month 07 Day

Anticipated trial start date

2024 Year 10 Month 07 Day

Last follow-up date

2025 Year 07 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

In this study, we will conduct a systematic review and meta-analysis of research papers investigating the impact of antibiotic use in patients after hematopoietic stem cell transplantation on outcomes due to graft-versus-host disease. This study complies with PRISMA guidelines.


Management information

Registered date

2024 Year 10 Month 07 Day

Last modified on

2025 Year 04 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063726